HOME › DRUGS › DOSTARLIMAB
ACTIVE SUBSTANCE / INN

DOSTARLIMAB

Brand name(s): Jemperli
EMA LISTED
AUTHORISED
Endometrial Neoplasms
ACTIVE SUBSTANCE
Dostarlimab
REGULATORS
EMA
SPONSORS / MAH
GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
JemperliGlaxoSmithKline Trading Services LimitedAuthorised21/04/2021Endometrial Neoplasms

FULL INTELLIGENCE ON DOSTARLIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →